(Total Views: 273)
Posted On: 08/13/2019 10:00:41 AM
Post# of 25428
$DMPI News Article - DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM) https://marketwirenews.com/news-releases/delm...31654.html
(0)
(0)
My Twitter: WhyteStocks
